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Abstract
Mint/X11 is one of the four neuronal trafﬁcking adaptors that
interact with amyloid precursor protein (APP) and are linked
with its cleavage to generate b-amyloid peptide, a key player
in the pathology of Alzheimer’s disease. How APP switches
between adaptors at different stages of the secretory pathway
is poorly understood. Here, we show that tyrosine phospho-
rylation of Mint1 regulates the destination of APP. A canonical
SH2-binding motif (202YEEI) was identiﬁed in the N-terminus of
Mint1 that is phosphorylated on tyrosine by C-Src and recruits
the active kinase for sequential phosphorylation of further
tyrosines (Y191 and Y187). A single Y202F mutation in the
Mint1 N-terminus inhibits C-Src binding and tyrosine phos-
phorylation. Previous studies observed that co-expression of
wild-type Mint1 and APP causes accumulation of APP in the
trans-Golgi. Unphosphorylatable Mint1 (Y202F) or pharmaco-
logical inhibition of Src reduced the accumulation of APP in the
trans-Golgi of heterologous cells. A similar result was
observed in cultured rat hippocampal neurons where Mint1
(Y202F) permitted the trafﬁcking of APP to more distal neurites
than the wild-type protein. These data underline the impor-
tance of the tyrosine phosphorylation of Mint1 as a critical
switch for determining the destination of APP.
Keywords: amyloid precursor protein, intracellular trafﬁcking,
Mint1, protein phosphorylation, Src, tyrosine kinase.
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Alzheimer’s disease (AD) is caused by the toxicity of soluble
b-amyloid oligomers that arise from the cleavage of amyloid
precursor protein (APP) by secretase enzymes (Shankar and
Walsh 2009). APP is ubiquitous in the body and although its
exact function is unclear, the consensus is that APP is a
receptor and/or cell adhesion molecule (Zheng and Koo
2011). APP and APP-like protein knockout and knock-in
experiments in various model organisms have implicated the
protein in neuronal development and synaptic function,
including plasticity (Muller et al. 1994; Seabrook et al.
1999; Merdes et al. 2004). However, the fact that b-amyloid
accumulation is mainly restricted to the brain in AD suggests
it is because of neuronal-speciﬁc interactors and/or the
demands of trafﬁcking APP long distances from the neuronal
cell soma to distal synapses.
APP trafﬁcking and processing is coordinated by several
multi-domain adapter proteins, including Dab1&2, Fe65,
JIP1 and Mint1,2,3/X11a,b,c, that interact with the C-
terminus of APP via phosphotyrosine-binding (PTB)
domains and link APP to a host of factors, including sorting,
signalling and motor proteins (Kawasumi et al. 2004; King
and Scott Turner 2004). Of these, Dab1, Fe65 and Mint1 and
2 are neuron speciﬁc. Because the proper processing of APP
relies on its co-localisation with the correct secretase
enzymes, disruption of APP–adapter interactions often
affects APP trafﬁcking and proteolysis, leading to increased
production of b-amyloid peptide (Sastre et al. 1998; Lau
et al. 2000; Mueller et al. 2000; Ando et al. 2001; Ho et al.
2002, 2008; Hoe et al. 2008; Kondo et al. 2010). It is
hypothesised that each adapter is responsible for a speciﬁc
step in the trafﬁcking and processing of APP, but how spatial
and temporal speciﬁcity in APP trafﬁcking is achieved is
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poorly understood. Phosphorylation certainly plays a role in
this process because APP can be phosphorylated on tyrosine
and threonine residues in its ‘YENPTY’ motif at the C-
terminus, which interacts with PTB domain- or SH2 domain-
containing adapters and the l subunit of AP-4 (Tarr et al.
2002; Burgos et al. 2010). Indeed, Fe65, Mint2 and JIP1
have differential afﬁnity for phosphorylated and unphospho-
rylated APP, however binding of Dab1 and Mint1 to APP is
unaffected by the phosphorylation status of APP (Borg et al.
1996; Ando et al. 2001; Tamayev et al. 2009), suggesting
alternative mechanisms might exist for their regulation.
In a search for a function of the N-terminus of Mint1 we
identiﬁed a canonical SH2 ligand (Y202EEI) that is phos-
phorylated by C-Src and mediates recruitment of the kinase
and the sequential phosphorylation of two adjacent Mint1
tyrosine residues. Stabilisation of APP metabolism by Mint1
is abolished by mutation of the C-Src phosphorylation site or
inhibition of Src, thus revealing a regulatory role for the
Mint1 N-terminus in interactions with APP. Furthermore,
trafﬁcking of APP to distal synapses in neurons is also
dependent on Mint-Y202. We propose that the phosphory-
lation status of Mint1-Y202 acts as a switch to regulate the
destination of APP.
Materials and methods
Materials
Anti-phosphotyrosine mouse monoclonal antibody (clone PY20)
was purchased from BD Bioscience (Oxford, UK). Rabbit mono-
clonal anti-myc and rabbit polyclonal anti-FLAG and anti-Src
pY416 were from Cell Signaling Technologies (Hitchin, UK). Rat
monoclonal anti-HA (clone 3F10) was from Roche (Welwyn
Garden City, UK). Rabbit anti-TGN46 was a gift from Dr Daniel
Ungar (University of York). Alexa-ﬂuor-conjugated secondary
antibodies were from Invitrogen (Paisley, UK). The Src family
kinase inhibitor, PP2, was obtained from Tocris-Cookson (Bristol,
UK). Rabbit polyclonal anti-GFP (green ﬂuorescent protein) was
from Insight Biotechnology (Wembley, UK). Afﬁnity-puriﬁed anti-
Mint-PY202 rabbit polyclonal antibody, raised to the peptide
CGLQEHVpYEEIGDA, was custom made by Genscript (Piscat-
away, NJ, USA). Unless stated otherwise, all other reagents were
from Sigma (Poole, UK).
Plasmids
All Mint1 plasmids were prepared by PCR from a mouse cDNA
clone (IMAGE ID 9055793) obtained from GeneService (Cam-
bridge, UK). Mammalian epitope-tagged Mint1 expression plasmids
comprised pMH-Mint(1-314)-HA and pMH-myc-Mint1(1-431),
pMH-myc-Mint1(1-842) and pmCerulean-N1-Mint(1-842). A plas-
mid encoding human APP(1-751)-FLAG in a pEGFP-N1 backbone
was prepared using IMAGE clone 6152423. Bacterial expression
plasmids included pGEX-6P1-Mint1(1-314), pGEX-6P1-Mint1(1-
431), pGEX-6P1-Mint3(1-180) and pQE30-myc-Mint(1-842). The
Mint1-Y202F mutation was introduced into the relevant Mint1
plasmids using the Quikchange system (Stratagene, Stockport, UK)
according to the manufacturer’s instructions. pGEX2T-Mint2(1-
341) and pQE30-Munc18 were generous gifts from the laboratory of
Prof Bob Burgoyne, University of Liverpool, UK. Plasmids for
expressing recombinant active His-C-Src in Escherichia coli,
pGEX4T-1-PTP1B-3C-His-Src(D80), and expressing C-Src-FLAG
in mammalian cells have been described elsewhere (Keenan et al.
2015). It should be noted that all bacterial and mammalian expressed
Mint1 proteins that contain the N-terminus had higher than predicted
molecular masses when separated by sodium dodecyl sulphate–
polyacrylamide gel electrophoresis (SDS-PAGE). For example,
GST-Mint(1-431), predicted Mr = 72 kDa, had an apparent Mr of
~ 120 kDa (Fig. 1b). We assume the discrepancy is because of the
nature of the primary structure of the Mint1 N-terminus.
Cell culture and transfection
Flp-in T-REx HeLa cells stably expressing Tet-inducible APP-
FLAG and COS-7 cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% foetal calf serum and
penicillin/streptomycin (Invitrogen). Cells were transfected 24 h
after plating with EcoTransfect transfection reagent according to the
manufacturer’s instructions (Oz Biosciences, Nottingham, UK).
Hippocampal and cortical neurons were prepared from newborn
Wistar rat pups of either sex (Harlan) as described previously
(Belﬁeld et al. 2006) and approved by the Biology Ethics
Committee, University of York. The animals were killed according
to Schedule 1 of the UK Home Ofﬁce Animals (Scientiﬁc
Procedures) Act. Neurons were cultured in Neurobasal medium
(Invitrogen) containing 2% B27 (Invitrogen), 5% foetal calf serum
(PAA Lab, Pasching, Austria), 1 mM L-glutamine, 35 mM glucose,
100 units/mL penicillin, and 0.1 mg/mL streptomycin (Invitrogen).
Cytosine arabinoside (2.4 lM) was added to the cultures 2–4 days
after plating to inhibit the proliferation of non-neuronal cells.
Hippocampal neurons were transfected with Lipofectamine 2000
according to the manufacturer’s instructions (Invitrogen).
Protein purification
Recombinant His and GST fusion proteins were expressed and
puriﬁed according to a previously described protocol (Evans et al.
2001). When necessary, GST was removed from fusion proteins by
incubation with PreScission protease (GE Healthcare) at 4°C
overnight.
In vitro phosphorylation
Phosphorylation reactions were prepared in kinase reaction buffer
(100 mM Tris-HCl pH 7.2, 25 mM MgCl2, 2 mM EGTA, 2 mM
dithiothreitol, 250 lM NaVO4
3 and 5 mM MnCl2). Reactions
were initiated by the addition of pre-warmed ATP (250 lM ﬁnal
concentration) to 10 lg protein substrate and 100 nM C-Src,
incubated at 30°C for 3 h and terminated by the addition of 29
SDS sample buffer (Sigma).
Mass spectrometry
In vitro untagged C-Src-phosphorylated Mint(1-314) was separated
from the other assay components of a similar mass [Src kinase and
bovine serum albumin (BSA)] by 2D gel electrophoresis using a ﬁrst
dimension of pH 3–10. The Coomassie-stained Mint protein spot
was sampled in four locations, each with increasing mass and
decreasing pI. Following sequential tryptic and chymotryptic
digestion, peptides were subjected to reversed phase LC-MS/MS
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using a Dionex Ultimate HPLC with a polystyrene–divinylbenzene
monolithic column coupled to either an Applied Biosystems
QSTAR Pulsar I or Bruker HCT ultra-mass spectrometer. Colli-
sion-induced dissociation mass spectra were searched against a
small custom database containing the Mint1 sequence. Phosphory-
lation sites were assigned using Mascot scores. ‘Delta score’
differences (Savitski et al. 2011) and manual inspection of spectra
were used to resolve ambiguities in site assignments.
Immunoprecipitation
Transfected COS-7 cells grown in 10 cm plates (107 cells/plate)
were lysed in ice-cold radioimmunoprecipitation assay buffer
(50 mM Tris pH 8.0, 150 mM NaCl, 1% TritonX-100, 0.5%
deoxycholate, 1 mM EDTA, 1 mM NaVO4
3) and incubated over-
night at 4°C with 25 lL Protein G resin (Genscript) and 3 lg of the
appropriate antibody. Beads were washed three times in radio-
immunoprecipitation assay buffer and proteins eluted in SDS sample
buffer and processed for western blotting.
Immunofluorescence
COS-7, HeLa cells or hippocampal neurons were cultured on No. 1
glass coverslips (coated with poly D-lysine for neurons) prior to
transfection. Culture media containing 1 lg/mL doxycycline was
applied to Flp-in T-REx HeLa cells to induce expression of APP-
FLAG for the indicated times. Cells were ﬁxed in 4% paraformalde-
hyde with 4% sucrose and then permeabilised for 30 min in
phosphate-buffered saline (PBS) with 1% BSA and 0.1% Triton X-
100. Primary antibody diluted in PBS with 1% BSA was applied for
1 h at 25C. After three washes in PBS, Alexa-ﬂuor-conjugated
secondary antibodies (1 : 500) were incubated for 30 min. Follow-
ing three further washes in PBS, coverslips were mounted in Mowial
mountant. Images were captured using a Zeiss LSM 710 Meta
confocal microscope in the Technology Facility, Department of
Biology, University of York or a Nikon TE200 epiﬂuorescence
microscope equipped with a Rolera-XR CCD camera (QImaging,
Surrey, BC, Canada).
Data analysis
Densitometric analysis of protein bands on western blots and
quantiﬁcation of particle number in COS-7 and HeLa immunoﬂuo-
rescent imageswas performed using ImageJ software (Abramoff et al.
2004). Neurite analysis of Mint- and APP-transfected hippocampal
neurons employed the NeuronJ plugin for ImageJ (Meijering et al.
2004). Where appropriate, statistical analysis of the data was
performed with SigmaPlot (Systat, San Jose, CA, USA) software
using one-way ANOVA with post hoc pair-wise comparisons by Holm–
Sidak tests. Chi-squared analysis was used to test the statistical
signiﬁcance of cell phenotype data. A Bonferroni correction was used
to correct for multiple comparisons.
Results
The Mint1 N-terminus is sequentially phosphorylated by
C-Src
The only functional domains previously deﬁned in the
variable N-termini of Mints1–3 are the Munc18-binding
domain in Mints 1 and 2 and the CASK interaction domain
in Mint1 (Fig. 1d). A search for further functional domains
or motifs in the Mint N-termini revealed a highly conserved
canonical C-Src phosphorylation site and SH2 ligand motif
(Songyang et al. 1993), YEEI, unique to Mint1 at Y202
(using numbering of the mouse protein, Genbank accession
NP_796008). Furthermore, the N-terminus of Mint1 is
tyrosine rich, suggesting the potential for multiple phospho-
rylation events by tyrosine kinases. In vitro kinase assays
using recombinant C-Src demonstrated tyrosine phosphory-
lation of the Mint1 N-terminus (1-314), comparatively weak
phosphorylation of the equivalent sequence in Mint2, and no
phosphorylation of Mint3 (Fig. 1a).
To investigate whether the predicted YEEI motif was
indeed targeted by C-Src, in vitro phosphorylated Mint1(1-
Fig. 1 The Mint1 N-terminus is phosphorylated sequentially by C-Src.
(a) Recombinant GST fusions of the N-terminal domains of Mint1
(1-314), Mint2(1-341) and Mint3(1-184) were subjected to an in vitro
kinase assay with C-Src. Tyrosine phosphorylation was detected by
immunoblotting (top panel) and protein loading was conﬁrmed by
Coomassie staining [bottom panel: asterisks indicate Mint proteins;
solid arrowhead = bovine serum albumin (BSA); hollow arrow-
head = C-Src]. Lower molecular weight proteolytic fragments of Mints
1 and 2 were also phosphorylated. (b) Twenty micrograms of
phosphorylated Mint1(1-314) was separated by 2D gel electrophoresis
and stained with Coomassie (asterisk, top panel; + = BSA and
# = dnaK). Phosphorylation was conﬁrmed by immunoblotting (as-
terisk, bottom panel). A schematic of the Mint1 spot indicates how it
was sampled at four sites by mass spectrometry. (c) Sequences and
masses of the predominant phosphopeptides identiﬁed in spots 1–4.
Phosphorylated tyrosine residues are highlighted in grey. (d) Sche-
matic of the domain structure of Mint1 indicating the location of the
three tyrosine residues sequentially phosphorylated by C-Src.
© 2016 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of
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314) was resolved by 2D gel electrophoresis and the protein
spot corresponding to tyrosine-phosphorylated protein (as
determined by western blotting; Fig. 1b) was analysed by
LC-MS/MS after digestion with trypsin and then chy-
motrypsin. The tryptic peptide 182-AEDEPYAEPYA-
DYGGLQEHVYEEIGDAPELEAR-214 was observed in
its mono-, di- and tri-phosphorylated forms, with phospho-
rylation of the YEEI motif at Y202 assigned in all three cases
and subsequent phosphorylation of Y191 and Y187 in the di-
and tri-phosphorylated forms (Fig 1c). All forms were
phosphorylated on Y202 and peptides containing intermedi-
ate phosphorylation of either Y187 or Y191 alone, or Y202
and Y187 together, were not observed. As expected, the
stoichiometry of phosphorylation of Mint1(182-214) was
higher in 2D gel spots with lower apparent pI values,
increasing from zero in spot 1 to three in spot 4 (Fig 1b).
Assignments of mono- and di-phosphorylated forms of the
chymotryptic peptide 180-HRAEDEPYAEPYADY-194
indicated that Y194 was not phosphorylated. Thus, we
concluded that Mint1 is sequentially phosphorylated by C-
Src in the order Y202, Y191 and Y187 as depicted in the
schematic in Fig. 1d. To conﬁrm the mass spectrometry data,
we mutated the ﬁrst predicted phosphorylation site, Y202, to
phenylalanine and found that it completely abolished in vitro
phosphorylation of Mint1(1-431) by C-Src (Fig. 2a).
Mint1-Y202 is tyrosine phosphorylated in cells and recruits
active C-Src to its N-terminal domain
To assess whether C-Src phosphorylates Mint1-Y202 in
cells, COS-7 ﬁbroblasts were transfected with myc-Mint1(1-
431) wild-type or a Y202F mutant. We found that in resting
cells we could not detect phosphorylation of immunoprecip-
itated myc-Mint1(1-431) by immunoblotting with a phos-
photyrosine antibody (Fig. 2b). However, activation of
tyrosine kinase signalling with sodium pervanadate, an
inhibitor of tyrosine phosphatases (Swarup et al. 1982),
induced detectable tyrosine phosphorylation of Mint1(1-431)
that was reduced in the Y202F-mutant protein (Fig. 2b).
In the light of the fact that Y202 is part of a canonical C-Src-
SH2 ligand, YEEI, we examined the possibility that Mint1 is a
scaffold for recruiting and activating C-Src, potentially
allowing the kinase to phosphorylate other proteins bound to
Mint1. Lysates from COS-7 cells transfected with Mint1(1-
431)-HA and C-Src-FLAG were incubated in the presence or
absence of pervanadate and then subjected to immunoprecip-
itation with anti-HA antibodies and processed for western
blotting. In agreement with the lack of resting phosphorylation
of Mint1 (Fig. 2b) co-immunoprecipitation of N-terminal
Mint1 with C-Src was barely detectable (Fig. 2c). However,
the binding was dramatically enhanced by treatment with
pervanadate. Furthermore, C-Src that was bound to Mint was
active, as shown by detection of C-Src auto-phosphorylation
on Y416 in the anti-HA Mint1 immunoprecipitations. Muta-
tion of Y202 in the Mint N-terminus to phenylalanine-
abolished binding of active C-Src (Fig. 2c), suggesting Y202
is the principle site for C-Src recruitment to the Mint1 N-
terminus.
The close proximity of Y202, Y187 and Y191 to the
minimal sequence in Mint1 known to be sufﬁcient for
Munc18 binding (amino acids 226–314; Okamoto and
Sudhof 1997) suggested that Mint1 tyrosine phosphorylation
might regulate binding to Munc18. However, no signiﬁcant
effect of C-Src phosphorylation on Mint1-Munc18 binding
was observed by in vitro GST pulldown assays (Fig. 3).
Mint1-Y202 regulates APP trafficking
We next considered the interaction of Mint1 with APP as a
possible target for regulation by C-Src phosphorylation. It
has been shown that co-expression of APP with Mint1 in
heterologous cells results in a dramatic increase in the
stability of APP that is hypothesised to be due to interaction
of Mints and APP in the trans-Golgi network (TGN;
Fig. 2 Mint1-Y202 is phosphorylated in cells and recruits C-Src
kinase. (a) Recombinant GST Mint1(1-431) protein and a Y202F
mutant were subjected to the same phosphorylation assay described
in Fig. 1a. The samples were processed for tyrosine phosphorylation
(PY; top panel) and protein loading (Coomassie; bottom panel).
(b) COS-7 cells transfected with either wild-type or mutant (Y202F)
myc-Mint1 N-terminus (1-431) were treated with or without NaVO4
3
prior to immunoprecipitation with anti-myc antibodies. Immunoprecip-
itated Mint1 (top panel) and tyrosine phosphorylated Mint1 (bottom
panel) were detected by immunoblotting. (c) COS-7 cells transfected
with C-Src-FLAG and either wild-type or mutant (Y202F) Mint1-HA N-
terminus (1-431) were treated with or without NaVO4
3 prior to
immunoprecipitation with anti-HA antibodies. Input (bottom panel) or
immunoprecipitated (top panel) Mint1, total C-Src-FLAG and active C-
Src phosphorylated on Y416 were detected by immunoblotting. All gels
and immunoblots are representative of three independent experi-
ments.
© 2016 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of
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McLoughlin et al. 1999; Mueller et al. 2000; Biederer et al.
2002). In support, we also demonstrated that co-expression
of Mint1 increased the stability of APP as detected by
western blotting (Fig 4a and b) and induced a perinuclear
accumulation of Mint1 and APP that co-localised with a
TGN-46 positive compartment (Fig 4d). Analysis of APP
puncta in these cells by immunoﬂuorescence demonstrated a
reduced number of cytosolic APP puncta compared to APP
expression alone (Fig. 4c). However, when Mint1-Y202F
was co-expressed with APP there was a signiﬁcant reduction
in APP immunoreactivity and a signiﬁcant increase in the
number of APP puncta (Fig. 4c and d). To conﬁrm that the
effects of Y202 mutation on APP trafﬁcking were because of
an inhibition of Mint1 phosphorylation by Src, we repeated
the co-expression of APP and Mint in COS-7 cells in the
presence or absence of the Src family kinase inhibitor PP2
(Hanke et al. 1996) or its inactive analogue PP3 (Fig 5). PP3
had no effect on the localisation of APP puncta previously
observed in Fig. 4. However, following incubation with PP2,
despite perinuclear co-localisation of Mint 1 and APP, there
was an increase in cytosolic APP puncta, suggesting Src
inhibition had partially reversed the perinuclear accumulation
of APP by Mint1. PP2 had no effect on the Mint1-Y202F-
dependent trafﬁcking of APP, consistent with the point
mutation inhibiting the effect of Src on Mint1 function and
not acting as a general loss-of-function mutation.
To investigate whether the accumulation of Mint1 was
affecting Golgi exit of APP or a block in recycling, we
generated a stable tetracycline-inducible APP-FLAG-expres-
sing ﬂp-in HeLa cell line in which we transfected wild-type
Fig. 3 Tyrosine phosphorylation of Mint1 does not regulate Munc18
binding. GST or GST-Mint1(1-314) were incubated in duplicate in the
presence or absence of C-Src kinase prior to incubation with
glutathione resin and bacterial lysate containing recombinant His-
Munc18. Following washing, Munc18 present in the bound fraction or
in 0.5% of the input lysate was detected by immunoblotting (top panel).
Phosphorylation of Mint1 was conﬁrmed by anti-phosphotyrosine
(middle panel). Protein levels were determined by Coomassie staining
of the PVDF membrane (bottom panel). The immunoblots are
representative of three independent experiments.
Fig. 4 Mint1-Y202 regulates amyloid precursor protein (APP) meta-
bolism. (a) COS-7 cells transfected in triplicate with APP-FLAG and
empty vector or myc-Mint1-WT or -Y202F were processed for
immunoblotting with anti-FLAG and anti-myc antibodies. (b) APP
immunoreactivity was quantiﬁed by densitometry and normalised to
APP + Mint1-WT. Data are plotted as mean  SEM, n = 3 separate
experiments, each performed in triplicate. **p < 0.01, ***p < 0.001.
(c) COS-7 cells transfected as described in (a) were subjected to
immunocytochemistry with anti-FLAG (APP) and anti-myc (Mint1)
antibodies and the number of FLAG reactive puncta/cell was counted
using ImageJ software in myc positive cells. Data are from ≥ 20 cells
per condition, ***p < 0.001. (d) Representative images are shown of
COS-7 cells transfected with APP-FLAG and CFP or CFP-Mint1-WT or
-Y202F that were stained with anti-FLAG (red) and anti-TGN-46
(green) antibodies. Merged images are of the red and green channels
only. Scale bar = 10 lm.
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or Y202F-mutant Mint. Twenty-four hours after Mint1
transfection, FLAG-APP expression was induced with
doxycycline and the localisation and number of APP puncta
was monitored over time (Fig. 6a). Intracellular APP puncta
were detectable from 3 h post-induction, with no statistical
difference in APP localisation between conditions at 3, 6 and
12 h (All p values > 0.1, a value = 0.0166). Twenty-four
hours after APP induction, cells expressing Mint1-Y202F
and APP alone had a similar APP distribution to 3 h, with
90% and 78% of APP, respectively, being cytoplasmic. In
contrast, 26% of cells expressing wild-type Mint1 had large
perinuclear puncta (Fig 6a; p < 0.0001 compared with other
conditions) and the total number of APP puncta concomi-
tantly decreased (Fig 6b). Conversely, Mint1-Y202F trans-
fection caused an increase in APP puncta at all time points
(Fig 6b). We concluded that Mint1 is unlikely to affect the
initial exit of APP from the Golgi but regulates an aspect of
APP recycling and that this activity is dependent on Y202.
Mint1-Y202 alters the localisation of APP in neurons
To detect phosphorylation of endogenous Mint1 in neurons,
we generated an afﬁnity-puriﬁed phosphospeciﬁc antibody to
a 12mer peptide of the Mint sequence centred on phospho-
Y202 (as described in Materials and methods section). The
antibody detected phosphorylation of recombinant Mint1 N-
terminus expressed in tyrosine kinase expressing TKX
bacteria (Fig. 7a) and in vitro phosphorylation of full length
His-Mint1-WT but not His-Mint1-Y202F (Fig. 7a). As
observed in COS-7 cells, the antibody did not detect Y202
phosphorylation under resting conditions, but revealed Mint1
phosphorylation in cortical neurons in which tyrosine kinases
were activated by treatment with sodium pervanadate
(Fig. 7b). The phosphorylation of Mint1 and Src kinases
was abolished by pre-treatment with the Src family kinase
inhibitor PP2 (Fig 7b).
To discover whether Mint1-Y202 regulates APP trafﬁck-
ing in neurons, the co-expression of APP and Mint1 plasmids
Fig. 5 Regulation of amyloid precursor protein (APP) trafﬁcking by
Mint1 is Src dependent. COS-7 cells were transfected with APP-FLAG
and empty myc vector (pMH) or myc-Mint1-WT or -Y202F and then
incubated in the presence of 5 lM PP2 or its inactive analogue, PP3,
for 48 h prior to immunocytochemistry with anti-FLAG (APP; red) and
anti-myc (Mint1; green) antibodies. Representative images are shown
of merged red and green channels except for APP alone which was co-
transfected with an empty vector. Scale bar = 10 lm.
Fig. 6 Amyloid precursor protein (APP) recycling is Mint1-Y202
dependent. Tetracycline-inducible APP-FLAG Flp-in HeLa cells were
transfected with CFP, CFP-Mint1-WT or -Y202F and then induced to
express APP-FLAG for 3, 6, 12 or 24 h prior to processing for
immunoﬂuorescence with anti-FLAG or anti-CFP antibodies. (a) Top
panels show representative grey scale images of cells with APP-FLAG
immunoreactivity predominantly cytoplasmic, perinuclear or distributed
between the two (cytoplasmic and perinuclear). Cells from each time
point were then classiﬁed into one of the three phenotypes according
to the localisation of APP-FLAG puncta. Data are plotted as percent-
ages, n ≥ 30 cells for each condition. (b) The number of APP-FLAG
reactive puncta in each CFP positive cell was quantiﬁed using ImageJ
software. Data are plotted as mean  SEM, from ≥ 30 cells per
condition. Pair-wise chi-squared statistical analysis was carried out for
each condition, with Bonferroni correction. ***p < 0.0001, comparing
all conditions at 24 h.
© 2016 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of
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was replicated in cultured hippocampal neurons. Here the
effect was more striking as co-expression of wild-type Mint1
prevented APP from entering neurites and caused accumu-
lation in the cell soma (Fig. 8a). Again, this phenotype was
rescued when APP was co-expressed with Mint1-Y202F. We
quantiﬁed the morphology of neurites stained for APP and
Mint1 and found signiﬁcant inhibition by wild-type Mint1,
but not Mint1-Y202F, of the number and total length of
neurites occupied by APP (Fig. 8b and c). Therefore the
Mint1-dependent reduction in APP trafﬁcking is not just
limited by its distance from the cell soma, but also its ability
to trafﬁc into certain processes.
Discussion
We have discovered a novel sequential tyrosine phosphory-
lation of the Mint1 N-terminus by C-Src kinase. The speciﬁc
downstream consequences of these phosphorylation events
are the recruitment of active C-Src and the regulation of APP
sorting at the TGN. Our data identify Y202 as a determinant
for Mint1-dependent APP accumulation in the TGN and
could have implications for the pathological trafﬁcking of
APP in AD.
Phosphorylation of the Mint1 N-terminus by C-Src in vitro
was only detected on Y202, Y191 and Y187 by mass
spectrometry. Other tyrosine residues in Mint1 have been
shown to be phosphorylated in brain samples in phospho-
proteomic screens (Wisniewski et al. 2010), but mutation of
Y202 completely abrogated C-Src binding and hence we
propose that Y202, Y191 and Y187 are the only N-terminal
C-Src phosphorylation sites in vivo. The residual tyrosine
phosphorylation of Mint1(1-431)-Y202F in vanadate treated
COS-7 cells (Fig. 2b) is likely due to phosphorylation by
other tyrosine kinases. An explanation for why Y202
phosphorylation has not been previously detected in the
brain by phosphoproteomic screens is that such studies are
often conducted on resting cells or tissue. It is likely that
under these conditions, the stoichiometry of phosphorylation
at Y202 is low, similar to what we have observed in
heterologous cells and cultured neurons. In support, the only
references to Mint1 Y202 phosphorylation that appear in the
PhosphoSitePlus database refer to in-house-curated data sets
from Jurkat cells treated with the phosphatase inhibitors
pervanadate and calyculin A (Hornbeck et al. 2012). There-
fore, phosphorylation of Y202 cycles rapidly and/or is only
increased when C-Src is strongly activated.
The principal effects of preventing tyrosine phosphory-
lation of Mint1 were a decrease in the accumulation of APP
in the TGN and enhanced transport of APP along neurites
in neurons. Using inducible expression of APP, we
demonstrated that the accumulation of APP likely arises
after its endocytosis rather than prior to its initial secretion.
Following internalisation, APP is sorted from early endo-
somes either to the TGN by the retromer complex or to the
late endo-lysosomal system (Vieira et al. 2010; Bhalla
et al. 2012; Choy et al. 2012). Thus, the accumulation of
APP in the TGN by co-expression of wild-type Mint1 with
APP could be due to the exclusive sorting of all internalised
APP by the retromer complex and/or an inhibition of APP
exit from the TGN. Conversely, Mint(Y202F) that cannot
be phosphorylated favours exit from the TGN and permits
axonal transport of APP. This supports the idea that in
healthy neurons, transient turnover of C-Src phosphoryla-
tion of Mint1 slows APP trafﬁcking in the TGN. A similar
function has been attributed to the APP sorting receptor and
AD risk factor, SORL1, whose over-expression also leads
to the perinuclear accumulation of APP and an inhibition of
its transport in neurites (Schmidt et al. 2007; Fjorback
et al. 2012). It is hypothesised that SORL1-dependent
retention of APP in the TGN reduces its amyloidogenic
processing and b-amyloid peptide secretion (Willnow and
Andersen 2013). It would be interesting to investigate
whether Mint1 and/or Src interacts with or regulates
SORL1.
We observed very weak phosphorylation of the Mint2 N-
terminus and no phosphorylation of the Mint3 N-terminus in
our in vitro kinase assay using recombinant C-Src. The lack
Fig. 7 Mint1 is phosphorylated on Y202 in cultured neurons. (a) A
phosphospeciﬁc antibody (anti-Mint-PY202) raised to a peptide con-
taining phospho-Y202 was tested for speciﬁcity on lysates of recom-
binant N-terminal Mint1 expressed in TKX bacteria (left panel) and full
length Mint1-WT and -Y202F phosphorylated in vitro by C-Src (right
panel). The lower band of ~ 90 kDa in the right panels represents a
proteolytic fragment of full length Mint1. (b) Lysates from cortical
neurons incubated in the presence or absence of 100 lM sodium
pervanadate and/or 10 lM PP2 were processed for immunoblotting
with anti-Mint1-pY202, anti-Src-pY416 (active Src) or anti-bIII-tubulin.
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of Mint3 tyrosine phosphorylation suggests Src phosphory-
lation of Mints 1 and 2 is a neuronal adaptation of its
function and hence consistent with its role in neuronal APP
trafﬁcking. A previous study focussing on Mint2 tyrosine
phosphorylation, also found the extent of Mint1 phosphory-
lation by C-Src in vitro and in cells was many fold higher
than that of Mint2 (Chaufty et al. 2012). Y202 is not
conserved in the Mint2 sequence suggesting the tyrosine
phosphorylation we have characterised is another difference
between these isoforms in addition to the CASK-binding site
identiﬁed in the Mint1 N-terminus (Borg et al. 1998).
Furthermore, preventing Mint2 tyrosine phosphorylation by
Src had a different effect on APP trafﬁcking to what we
observed for Mint1. An un-phosphorylatable mutant of
Mint2 (Y86,110,193F) caused Mint2 to accumulate in the
Golgi, but promoted APP recycling (Chaufty et al. 2012). In
further contrast to Mint1, wild-type Mint2 was found to have
no effect on the stability of APP or its perinuclear
accumulation (Chaufty et al. 2012). Thus, the N-terminal
phosphorylation of Mints 1 and 2 has the potential to
differentially regulate APP trafﬁcking.
How might multisite tyrosine phosphorylation of Mint1
by C-Src regulate APP at the molecular level? First, Mint1
phosphorylation could allosterically regulate the interaction
between its PTB domain and the APP C-terminus. There are
conﬂicting data regarding this mode of regulation, for
example, deletion of the Mint1 N-terminus inhibits the
effect of the full length protein on APP processing (Mueller
et al. 2000) and Sakuma et al. (2009) showed that stress-
induced serine phosphorylation of the Mint1/2 N-terminus
Fig. 8 Mint1-Y202 controls neuronal trafﬁcking of amyloid precursor
protein (APP). (a) Representative ﬂuorescence images of cultured
hippocampal neurons transfected with EGFP, myc-Mint-WT or myc-
Mint-Y202F (top panels, grey scale) and APP-FLAG (middle panels,
grey scale). Bottom panels show merge of red and green channels. The
extent of APP trafﬁcking was quantiﬁed by calculating the neurite length
(b) or neurite number (c) occupied by APP staining as a percentage of
that occupied by EGFP or Mint staining. Data are mean  SEM, n = 3
individual experiments (10–15neurons analysed/condition/experiment).
*p < 0.05 compared to EGFP or Mint-Y202F. Scale bar = 20 lm.
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reduces APP binding. However, it was shown that tyrosine
phosphorylation of Mint2 regulates APP trafﬁcking without
altering binding to APP (Chaufty et al. 2012). It is also
possible that wild-type Mint1 is acting via secondary
interactions that are mediated by tyrosine phosphorylation.
Surprisingly, we did not see phosphorylation-dependent
binding to Munc18 despite Y202, Y191 and Y187 being
adjacent to the Munc18-binding domain of Mint1 (Okamoto
and Sudhof 1997). In addition to the recruitment of C-Src
itself, the three phosphorylated tyrosine residues of Mint1
might act as SH2 ligands for other signalling proteins, as
observed in other multisite substrates of Src, such as p130cas
(Cary et al. 1998). Identiﬁcation of the phosphospeciﬁc
binding partners of Mint1 could help explain the radically
different APP localisation we observe between the wild-type
and Y202F forms of Mint1 in neurons.
While the signalling adaptors Shc and Grb2 are recruited
to the tyrosine-phosphorylated tail of APP (Tarr et al. 2002;
Zhou et al. 2004), the binding of the three major PTB
domain-containing APP adaptors, Dab1, Fe65 and Mint, are
unaffected by APP tyrosine phosphorylation (Ando et al.
2001; Tamayev et al. 2009). However, Dab1 interacts with
Fyn and Fe65 interacts with Abl, to regulate APP at the cell
surface (Zambrano et al. 2001; Hoe et al. 2008), and we
now show that Mint1 can interact with C-Src to alter the
trafﬁcking of APP at the TGN. Taken together, PTB-
containing adaptors act as scaffolds to recruit and activate
non-receptor tyrosine kinases to orchestrate the different
stages of APP trafﬁcking.
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